Stewart Shuman

Person

Carlsbad, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof...
- Patent number 12,036,279
- Issue date Jul 16, 2024
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Replication competent attenuated vaccinia viruses with deletion of...
- Patent number 11,986,503
- Issue date May 21, 2024
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vaccinia virus mutants useful for cancer immunotherapy
- Patent number 11,884,939
- Issue date Jan 30, 2024
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Replication competent attenuated vaccinia viruses with deletion of...
- Patent number 11,541,087
- Issue date Jan 3, 2023
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of inactivated nonreplicating modified vaccinia virus Ankara (M...
- Patent number 11,426,460
- Issue date Aug 30, 2022
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Recombinant MVA or MVAΔE3L expressing human FLT3L and use thereof a...
- Patent number 11,285,209
- Issue date Mar 29, 2022
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of MVA or MVAΔE3L as immunotherapeutic agents against solid tumors
- Patent number 11,253,560
- Issue date Feb 22, 2022
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vaccinia virus mutants useful for cancer immunotherapy
- Patent number 11,242,509
- Issue date Feb 8, 2022
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Replication competent attenuated vaccinia viruses with deletion of...
- Patent number 10,765,711
- Issue date Sep 8, 2020
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof...
- Patent number 10,736,962
- Issue date Aug 11, 2020
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of inactivated nonreplicating modified vaccinia virus Ankara (M...
- Patent number 10,639,366
- Issue date May 5, 2020
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of MVA or MVAΔE3L as immunotherapeutic agents against solid tumors
- Patent number 10,548,930
- Issue date Feb 4, 2020
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Replication competent attenuated vaccinia viruses with deletion of...
- Patent number 10,512,662
- Issue date Dec 24, 2019
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for molecular cloning and polynucleotide synthesis using vac...
- Patent number 8,551,739
- Issue date Oct 8, 2013
- Memorial Sloan Kettering Cancer Center
- Stewart Shuman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Covalent joining of DNA strands to RNA strands catalyzed by vaccini...
- Patent number 8,192,932
- Issue date Jun 5, 2012
- Sloan-Kettering Institute for Cancer Research
- Stewart Shuman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Covalent joining of DNA to RNA by vaccinia topoisomerase and uses t...
- Patent number 7,662,556
- Issue date Feb 16, 2010
- Sloan-Kettering Institute for Cancer Research
- Stewart Shuman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method for molecular cloning and polynucleotide synthesis using vac...
- Patent number 7,550,295
- Issue date Jun 23, 2009
- Sloan-Kettering Institute for Cancer Research
- Stewart Shuman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and reagents for molecular cloning
- Patent number 7,528,241
- Issue date May 5, 2009
- Life Technologies Corporation
- Jonathan D. Chesnut
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Topoisomerase-based reagents and methods for molecular cloning
- Patent number 7,026,141
- Issue date Apr 11, 2006
- Sloan-Kettering Institute for Cancer Research
- Stewart Shuman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and reagents for molecular cloning
- Patent number 6,916,632
- Issue date Jul 12, 2005
- Invitrogen Corporation
- Jonathan D. Chesnut
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Pharmacological targeting of mRNA cap formation for treatment of pa...
- Patent number 6,844,167
- Issue date Jan 18, 2005
- Stewart Shuman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Pharmacological targeting of bacterial DNA ligase for treatment and...
- Patent number 6,787,341
- Issue date Sep 7, 2004
- Sloan-Kettering Institute for Cancer Research
- Stewart Shuman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Topoisomerase-based ligation and cloning methods
- Patent number 6,653,106
- Issue date Nov 25, 2003
- Sloan-Kettering Institute for Cancer Research
- Stewart Shuman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method for molecular cloning and polynucleotide synthesis using vac...
- Patent number 6,548,277
- Issue date Apr 15, 2003
- Sloan-Kettering Institute for Cancer Research
- Stewart Shuman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Pharmacological targeting of mRNA cap formation for treatment of pa...
- Patent number 6,451,583
- Issue date Sep 17, 2002
- Stewart Shuman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Pharmacological targeting of mRNA cap formation
- Patent number 6,420,163
- Issue date Jul 16, 2002
- Stewart Shuman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Pharmacological targeting of mRNA cap formation
- Patent number 6,232,070
- Issue date May 15, 2001
- Stewart Shuman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Pharmacological targeting of mRNA cap formation
- Patent number 6,107,040
- Issue date Aug 22, 2000
- Stewart Shuman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method for molecular cloning and polynucleotide synthesis using vac...
- Patent number 5,766,891
- Issue date Jun 16, 1998
- Sloan-Kettering Institute for Cancer Research
- Stewart Shuman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
REPLICATION COMPETENT ATTENUATED VACCINIA VIRUSES WITH DELETION OF...
- Publication number 20230310526
- Publication date Oct 5, 2023
- Memorial Sloan-Kettering Cancer Center
- Liang DENG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RECOMBINANT MVA OR MVADELE3L EXPRESSING HUMAN FLT3L AND USE THEREOF...
- Publication number 20230057304
- Publication date Feb 23, 2023
- Memorial Sloan-Kettering Cancer Center
- Liang DENG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
REPLICATION COMPETENT ATTENUATED VACCINIA VIRUSES WITH DELETION OF...
- Publication number 20220339221
- Publication date Oct 27, 2022
- Memorial Sloan-Kettering Cancer Center
- Liang DENG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF MVA OR MVADELTAE3L AS IMMUNOTHERAPEUTIC AGENTS AGAINST SOLID...
- Publication number 20220211785
- Publication date Jul 7, 2022
- Memorial Sloan-Kettering Cancer Center
- Liang DENG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VACCINIA VIRUS MUTANTS USEFUL FOR CANCER IMMUNOTHERAPY
- Publication number 20220186192
- Publication date Jun 16, 2022
- Memorial Sloan-Kettering Cancer Center
- Liang Deng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RECOMBINANT POXVIRUSES FOR CANCER IMMUNOTHERAPY
- Publication number 20220056475
- Publication date Feb 24, 2022
- Memorial Sloan-Kettering Cancer Center
- Liang DENG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HEAT-INACTIVATED VACCINIA VIRUS AS A VACCINE IMMUNE ADJUVANT
- Publication number 20210177964
- Publication date Jun 17, 2021
- Memorial Sloan-Kettering Cancer Center
- Liang DENG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ONCOLYTIC VACCINIA VIRUS EXPRESSING IMMUNE CHECKPOINT BLOCKADE FOR...
- Publication number 20210023151
- Publication date Jan 28, 2021
- Memorial Sloan-Kettering Cancer Center
- Liang DENG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
VACCINIA VIRUS MUTANTS USEFUL FOR CANCER IMMUNOTHERAPY
- Publication number 20200339959
- Publication date Oct 29, 2020
- Memorial Sloan-Kettering Cancer Center
- Liang Deng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RECOMBINANT MVA OR MVADELE3L EXPRESSING HUMAN FLT3L AND USE THEREOF...
- Publication number 20200316198
- Publication date Oct 8, 2020
- Memorial Sloan-Kettering Cancer Center
- Liang DENG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF INACTIVATED NONREPLICATING MODIFIED VACCINIA VIRUS ANKARA (M...
- Publication number 20200237902
- Publication date Jul 30, 2020
- Memorial Sloan-Kettering Cancer Center
- Liang Deng
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
REPLICATION COMPETENT ATTENUATED VACCINIA VIRUSES WITH DELETION OF...
- Publication number 20200237839
- Publication date Jul 30, 2020
- Memorial Sloan-Kettering Cancer Center
- Liang DENG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF MVA OR MVADELTAE3L AS IMMUNOTHERAPEUTIC AGENTS AGAINST SOLID...
- Publication number 20200222479
- Publication date Jul 16, 2020
- Memorial Sloan-Kettering Cancer Center
- Liang DENG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
REPLICATION COMPETENT ATTENUATED VACCINIA VIRUSES WITH DELETION OF...
- Publication number 20190054131
- Publication date Feb 21, 2019
- Memorial Sloan-Kettering Cancer Center
- Liang DENG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RECOMBINANT MVA OR MVADELE3L EXPRESSING HUMAN FLT3L AND USE THEREOF...
- Publication number 20190046640
- Publication date Feb 14, 2019
- Memorial Sloan-Kettering Cancer Center
- Liang DENG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF INACTIVATED NONREPLICATING MODIFIED VACCINIA VIRUS ANKARA (M...
- Publication number 20180236062
- Publication date Aug 23, 2018
- Memorial Sloan-Kettering Cancer Center
- Liang Deng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF MVA OR MVADELTAE3L AS IMMUNOTHERAPEUTIC AGENTS AGAINST SOLID...
- Publication number 20180078591
- Publication date Mar 22, 2018
- Memorial Sloan-Kettering Cancer Center
- Liang DENG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND REAGENTS FOR MOLECULAR CLONING
- Publication number 20150093788
- Publication date Apr 2, 2015
- Life Technologies Corporation
- Jonathan CHESNUT
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Covalent Joining of DNA Strands to RNA Strands Catalyzed by Vaccini...
- Publication number 20120322109
- Publication date Dec 20, 2012
- STEWART SHUMAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND REAGENTS FOR MOLECULAR CLONING
- Publication number 20120129225
- Publication date May 24, 2012
- Life Technologies Corporation
- Jonathan D. Chesnut
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Covalent joining of DNA strands to RNA strands catalyzed by vaccini...
- Publication number 20100317064
- Publication date Dec 16, 2010
- Sloan-Kettering Institute For Cancer Research
- Stewart Shuman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND REAGENTS FOR MOLECULAR CLONING
- Publication number 20090328244
- Publication date Dec 31, 2009
- Life Technologies Corporation
- Jonathan D. Chesnut
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Method for molecular cloning and polynucleotide synthesis using vac...
- Publication number 20090068708
- Publication date Mar 12, 2009
- Sloan-Kettering Institute For Cancer Research
- Stewart Shuman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method for molecular cloning and polynucleotide synthesis using vac...
- Publication number 20060160072
- Publication date Jul 20, 2006
- Stewart Shuman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmacological targeting of bacterial DNA ligase for treatment and...
- Publication number 20060134642
- Publication date Jun 22, 2006
- Sloan-Kettering Institute For Cancer Research
- Stewart Shuman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Methods and reagents for molecular cloning
- Publication number 20050282184
- Publication date Dec 22, 2005
- Invitrogen Corporation
- Jonathan D. Chesnut
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Covalent joining of DNA to RNA by vaccinia topoisomerase and uses t...
- Publication number 20040058417
- Publication date Mar 25, 2004
- Sloan-Kettering Institute for Cancer Research
- Stewart Shuman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Topoisomerase-based reagents and methods for molecular cloning
- Publication number 20030215925
- Publication date Nov 20, 2003
- Stewart Shuman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmacological targeting of mRNA cap formation for treatment of pa...
- Publication number 20030166209
- Publication date Sep 4, 2003
- Stewart Shuman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Pharmacological targeting of bacterial DNA ligase for treatment and...
- Publication number 20030036647
- Publication date Feb 20, 2003
- Stewart Shuman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Stewart Shuman

Person

Patents Grantslast 30 patents

Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof...

Replication competent attenuated vaccinia viruses with deletion of...

Vaccinia virus mutants useful for cancer immunotherapy

Replication competent attenuated vaccinia viruses with deletion of...

Use of inactivated nonreplicating modified vaccinia virus Ankara (M...

Recombinant MVA or MVAΔE3L expressing human FLT3L and use thereof a...

Use of MVA or MVAΔE3L as immunotherapeutic agents against solid tumors

Vaccinia virus mutants useful for cancer immunotherapy

Replication competent attenuated vaccinia viruses with deletion of...

Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof...

Use of inactivated nonreplicating modified vaccinia virus Ankara (M...

Use of MVA or MVAΔE3L as immunotherapeutic agents against solid tumors

Replication competent attenuated vaccinia viruses with deletion of...

Method for molecular cloning and polynucleotide synthesis using vac...

Covalent joining of DNA strands to RNA strands catalyzed by vaccini...

Covalent joining of DNA to RNA by vaccinia topoisomerase and uses t...

Method for molecular cloning and polynucleotide synthesis using vac...

Methods and reagents for molecular cloning

Topoisomerase-based reagents and methods for molecular cloning

Methods and reagents for molecular cloning

Pharmacological targeting of mRNA cap formation for treatment of pa...

Pharmacological targeting of bacterial DNA ligase for treatment and...

Topoisomerase-based ligation and cloning methods

Method for molecular cloning and polynucleotide synthesis using vac...

Pharmacological targeting of mRNA cap formation for treatment of pa...

Pharmacological targeting of mRNA cap formation

Pharmacological targeting of mRNA cap formation

Pharmacological targeting of mRNA cap formation

Method for molecular cloning and polynucleotide synthesis using vac...

Patents Applicationslast 30 patents

REPLICATION COMPETENT ATTENUATED VACCINIA VIRUSES WITH DELETION OF...

RECOMBINANT MVA OR MVADELE3L EXPRESSING HUMAN FLT3L AND USE THEREOF...

REPLICATION COMPETENT ATTENUATED VACCINIA VIRUSES WITH DELETION OF...

USE OF MVA OR MVADELTAE3L AS IMMUNOTHERAPEUTIC AGENTS AGAINST SOLID...

VACCINIA VIRUS MUTANTS USEFUL FOR CANCER IMMUNOTHERAPY

RECOMBINANT POXVIRUSES FOR CANCER IMMUNOTHERAPY

HEAT-INACTIVATED VACCINIA VIRUS AS A VACCINE IMMUNE ADJUVANT

ONCOLYTIC VACCINIA VIRUS EXPRESSING IMMUNE CHECKPOINT BLOCKADE FOR...

VACCINIA VIRUS MUTANTS USEFUL FOR CANCER IMMUNOTHERAPY

RECOMBINANT MVA OR MVADELE3L EXPRESSING HUMAN FLT3L AND USE THEREOF...

USE OF INACTIVATED NONREPLICATING MODIFIED VACCINIA VIRUS ANKARA (M...

REPLICATION COMPETENT ATTENUATED VACCINIA VIRUSES WITH DELETION OF...

USE OF MVA OR MVADELTAE3L AS IMMUNOTHERAPEUTIC AGENTS AGAINST SOLID...

REPLICATION COMPETENT ATTENUATED VACCINIA VIRUSES WITH DELETION OF...

RECOMBINANT MVA OR MVADELE3L EXPRESSING HUMAN FLT3L AND USE THEREOF...

USE OF INACTIVATED NONREPLICATING MODIFIED VACCINIA VIRUS ANKARA (M...

USE OF MVA OR MVADELTAE3L AS IMMUNOTHERAPEUTIC AGENTS AGAINST SOLID...

METHODS AND REAGENTS FOR MOLECULAR CLONING

Covalent Joining of DNA Strands to RNA Strands Catalyzed by Vaccini...

METHODS AND REAGENTS FOR MOLECULAR CLONING

Covalent joining of DNA strands to RNA strands catalyzed by vaccini...

METHODS AND REAGENTS FOR MOLECULAR CLONING

Method for molecular cloning and polynucleotide synthesis using vac...

Method for molecular cloning and polynucleotide synthesis using vac...

Pharmacological targeting of bacterial DNA ligase for treatment and...

Methods and reagents for molecular cloning

Covalent joining of DNA to RNA by vaccinia topoisomerase and uses t...

Topoisomerase-based reagents and methods for molecular cloning

Pharmacological targeting of mRNA cap formation for treatment of pa...

Pharmacological targeting of bacterial DNA ligase for treatment and...